Whether you're visiting an oncologist for the first time or seeking a second opinion, asking the right questions can help you understand important information about your diagnosis.
The National Cancer Institute estimates that more than 87,000 new cases of melanoma were diagnosed in 2017. While not as common as other forms of skin cancer, melanoma is more aggressive, and if it's not diagnosed and treated early, it can spread rapidly to other organs. Within the last 10 years, however, researchers have developed new treatments that are giving patients hope.
When Shari Pimental underwent routine surgery two years ago to remove her gallbladder, she woke up in the recovery room and learned she had stage III ovarian cancer.
Dr. Kathleen Yang, Shari's gynecologic oncologist at Willamette Valley Cancer Institute, thought Shari could possibly benefit from a clinical trial at WVCI for an investigational drug, classified as a PARP inhibitor that's designed to block specific enzymes that cancer cells need to survive.
Santa doesn't always travel by sleigh. Sometimes, holiday goodwill takes alternate forms of transportation, including the white passenger van that recently pulled into the parking lot at Willamette Valley Cancer Institute and Research Center.
Every three minutes, an American is diagnosed with a form of blood cancer. Paul Leighton of Springfield realized he was part of that statistic in 2013, when he was diagnosed with acute myeloid leukemia, brought on by a disorder that prevents stem cells from maturing and accumulating in his bone marrow.
Diagnosed with ovarian cancer in 2013, Marcy Sexton has seen the inside of Willamette Valley Cancer Institute more times than she can count. Despite surgery and aggressive chemotherapy, Marcy's cancer returned in 2015, then again in 2017 in her liver. This time, one of the tumors was in a tricky spot.
When Brenda Mills of Springfield was diagnosed with stage 2 triple negative breast cancer in June of 2016, she knew she was in for the fight of her life, physically and mentally. What she didn't expect was that cancer would also cost a financial toll. When she needed support, the Oregon Cancer Foundation was there to help.
Jim Ketter, a former physics instructor at Oregon State University is among the first in the Willamette Valley to receive a new treatment for glioblastoma, the most common type of brain tumor in adults. Jim underwent surgery and radiation therapy, and now, in addition to receiving chemotherapy, he wears a cap-like device called Optune.
Shirley Lyons knows the power of flowers. For more than 40 years, Shirley and her family have owned and operated Dandelions Flowers & Gifts in Eugene. In 2012, she and her daughter, Toviana, found another way to help. They started Bras for Cause, a fundraiser to support local cancer patients.
Jeff Gusinow spent part of the summer doing something he hadn't planned: receiving treatment at Willamette Valley Cancer Institute. "I write on my Facebook page every week about how my 'staycation' is going, as if I were on a boat. So, this is the leido deck," Jeff says from where he sits in WVCI's infusion room. Jeff was diagnosed 11 years ago with a slow-growing blood cancer called follicular lymphoma, the most common form of Non-Hodgkin lymphoma. His cancer has now advanced to the point where treatment is recommended.